Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors (English, HTML)

View metadata and access the original English HTML file: Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors.

Format

HTML

Access

file-only

Publisher-reported update

2022-06-07

As set out in paragraph C.05.010(b) of the Food and Drug Regulations (FDR), clinical trials must follow certain requirements of the protocol. Health Canada authorizes this protocol and the Research Ethics Board approves it. During the pandemic, there may be more deviations from the established protocol.

Access original file